Indoxyl sulfate: clinical implications for anemia management in chronic kidney disease

By afschroeder • December 8, 2025

Rattanasompattikul M, Srithongkul T, Tantisattamo E, Kalantar-Zadeh K, Noppakun K. Indoxyl sulfate: clinical implications for anemia management in chronic kidney disease. Curr Opin Nephrol Hypertens. 2025 Dec 8. doi: 10.1097/MNH.0000000000001145. Epub ahead of print. PMID: 41355384.

Tags: dialysis modalities, erythropoiesis, gut microbiota, Harbor UCLA, iron metabolism, Nephrology, Publications, uremic toxins

Symptom status and non-calcified plaque burden across CAC strata: insights from AI-based CCTA quantification

Iskander B, Kambalapalli S, Punnanithinont N, Kinninger A, Krishnan S, Ichikawa K, Lakshmanan S, Roy S, Budoff MJ. Symptom status and non-calcified plaque burden across[...]

Sperm concentration in mail-in semen consistently reflects results obtained on freshly collected semen

Lue Y, Swerdloff R, Baravarian S, Pak Y, Hull L, Bremner W, Wang C. Sperm concentration in mail-in semen consistently reflects results obtained on freshly[...]

A Murine Model of Dermatophytosis

Nabeela S, Agrawal N, Uppuluri P. A Murine Model of Dermatophytosis. Curr Protoc. 2026 Jan;6(1):e70287. doi: 10.1002/cpz1.70287. PMID: 41532249.